Japan Approves Biosimilar Teriparatide And Darbepoetin

 
• By Aidan Fry

Japan’s first biosimilar teriparatide has been approved for Mochida Pharmaceutical, while competition in the darbepoetin alfa arena looks set to step up following two recent authorizations.

Bone_Structure
Mochida says it has received Japan's first approval for a biosimilar version of the osteoporosis drug teriparatide • Source: Shutterstock

More from Biosimilars

More from Products